Chemoinformaics analysis of 17-O-acetylajmaline
Molecular Weight | 368.477 | nRot | 2 |
Heavy Atom Molecular Weight | 340.253 | nRig | 25 |
Exact Molecular Weight | 368.21 | nRing | 7 |
Solubility: LogS | -3.81 | nHRing | 5 |
Solubility: LogP | 2.534 | No. of Aliphatic Rings | 6 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 1 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 55 | No. of Aliphatic Hetero Cycles | 5 |
No. of Heavy Atom | 27 | No. of Aromatic Carbocycles | 1 |
nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 5 | No. Saturated Carbocycles | 1 |
No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 4 |
No. of Carbon atom | 22 | No. of Saturated Rings | 5 |
No. of Nitrogen atom | 2 | No. of Arom Atom | 6 |
No. of Oxygen atom | 3 | No. of Arom Bond | 6 |
nHA | 5 | APOL | 60.0162 |
nHD | 1 | BPOL | 34.1138 |
QED | 0.811 |
Synth | 6.384 |
Natural Product Likeliness | 2.546 |
NR-PPAR-gamma | 0.009 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.046 |
Pgp-sub | 0.998 |
HIA | 0.936 |
CACO-2 | -5.072 |
MDCK | 0.0000534 |
BBB | 0.182 |
PPB | 0.733847 |
VDSS | 1.704 |
FU | 0.2726 |
CYP1A2-inh | 0.095 |
CYP1A2-sub | 0.067 |
CYP2c19-inh | 0.068 |
CYP2c19-sub | 0.563 |
CYP2c9-inh | 0.093 |
CYP2c9-sub | 0.145 |
CYP2d6-inh | 0.09 |
CYP2d6-sub | 0.756 |
CYP3a4-inh | 0.578 |
CYP3a4-sub | 0.647 |
CL | 6.656 |
T12 | 0.284 |
hERG | 0.222 |
Ames | 0.041 |
ROA | 0.53 |
SkinSen | 0.24 |
Carcinogencity | 0.135 |
EI | 0.015 |
Respiratory | 0.935 |
NR-Aromatase | 0.002 |
Antiviral | No |
Prediction | 0.750273 |